According to the research report published by Polaris Market Research, the global angioplasty balloons market was valued at USD 2.55 billion in 2021 and is expected to reach USD 3.44 billion by 2030, to grow at a CAGR of 3.4% during the forecast period.
Market Overview
Angioplasty balloons are critical components in percutaneous transluminal angioplasty (PTA) procedures, utilized to dilate narrowed or obstructed blood vessels, primarily in the treatment of coronary artery disease (CAD) and peripheral artery disease (PAD). The market encompasses various balloon types, including normal balloons, drug-eluting balloons (DEBs), cutting balloons, and scoring balloons, each designed to address specific clinical needs.
In 2024, normal balloons dominated the market, accounting for approximately 54.8% of the global share. Their widespread use is attributed to proven efficacy, cost-effectiveness, and ease of use in routine angioplasty procedures . However, drug-eluting balloons are gaining traction due to their ability to reduce restenosis rates and eliminate the need for permanent implants .
Key Market Growth Drivers
1. Rising Prevalence of Cardiovascular Diseases
Cardiovascular diseases remain the leading cause of mortality worldwide. According to the Centers for Disease Control and Prevention (CDC), approximately 5% of adults aged 20 and above suffer from CAD, necessitating interventions like angioplasty . The growing burden of heart diseases significantly contributes to the demand for angioplasty balloons.
2. Technological Advancements in Balloon Design
Innovations in angioplasty balloon technologies, such as the development of drug-eluting balloons (DEBs) and bioresorbable balloons, have enhanced procedural success rates and reduced complications. These advancements offer targeted drug delivery and improved lesion preparation, respectively, leading to better patient outcomes .
3. Shift Towards Minimally Invasive Procedures
The global healthcare landscape is witnessing a shift towards minimally invasive interventions, driven by benefits like reduced hospital stays, lower complication rates, and faster recovery times. Angioplasty balloons play a pivotal role in such procedures, further propelling market growth .
4. Aging Population and Lifestyle Changes
The increasing geriatric population, particularly in regions like Asia-Pacific, coupled with lifestyle-related risk factors such as smoking, sedentary habits, and unhealthy diets, has led to a surge in cardiovascular ailments. This demographic trend underscores the growing need for angioplasty interventions .
Market Challenges
1. Regulatory Hurdles and Approval Processes
The stringent regulatory frameworks governing medical devices can pose challenges for market entry and product approvals. Manufacturers must navigate complex compliance requirements, which can delay product launches and increase development costs .
2. High Costs Associated with Advanced Balloons
While advanced balloons like DEBs offer clinical benefits, their higher costs can limit adoption, especially in cost-sensitive markets. Healthcare providers and patients may opt for more affordable alternatives, impacting the market penetration of premium products .
3. Risk of Restenosis and Complications
Despite technological advancements, the risk of restenosis (re-narrowing of the artery) and other complications remains a concern. Continuous research and development are essential to mitigate these risks and improve long-term patient outcomes .
Regional Analysis
North America
North America holds a significant share of the angioplasty balloon market, driven by advanced healthcare infrastructure, high healthcare spending, and the presence of leading medical device manufacturers. The United States, in particular, accounts for over 90% of the North American market, attributed to the high prevalence of cardiovascular diseases and favorable reimbursement policies .
Europe
Europe is witnessing steady growth in the angioplasty balloon market, supported by increasing adoption of minimally invasive procedures and a growing elderly population. Countries like Germany, France, and the UK are at the forefront, with robust healthcare systems and ongoing technological innovations .
Asia-Pacific
The Asia-Pacific region is expected to experience the fastest growth during the forecast period, propelled by rising healthcare investments, increasing awareness of cardiovascular diseases, and expanding medical tourism. Countries such as China, India, and Japan are key contributors to this growth trajectory .
Latin America and Middle East & Africa
These regions are gradually emerging as potential markets for angioplasty balloons, driven by improving healthcare infrastructure and increasing prevalence of cardiovascular conditions. However, challenges like limited access to advanced medical technologies and economic constraints may hinder rapid growth .
Key Companies
- AngioDynamics
- B. Braun Melsungen AG.
- Becton Dickinson
- Biomerics
- BIOTRONIK Vertriebs GmbH & Co. KG
- Boston Scientific Corporation
- Cardinal Health
- Cordis (Cardinal Health)
- CTK biotech
- Inc
- Hexacath
- INFINITY Angioplasty Balloon
- JOTEC GmbH
- Koninklijke Philips N.V
- Medtronic Plc
- MicroPort Scientific Corporation
- Nipro Medical Corporation
Explore More:
https://www.polarismarketresearch.com/industry-analysis/global-angioplasty-balloon-market
Conclusion
The angioplasty balloon market is on an upward trajectory, fueled by the escalating burden of cardiovascular diseases, technological innovations, and a global shift towards minimally invasive procedures. While challenges like regulatory complexities and cost constraints persist, ongoing research, strategic partnerships, and expanding healthcare access in emerging economies are expected to drive sustained market growth.
More Trending Latest Reports By Polaris Market Research:
Testing, Inspection, and Certification Market
Fast Curing Nitrile Butadiene Rubber Market
Journey of Bioprocessing Analytics Equipment from Lab to Market
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek